CMN-005 by CoImmune for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval

NS Pharma’s NS-089/NCNP-02 (brogidirsen) is intended for patients with Duchenne muscular dystrophy. Credit: Jose Luis Calvo via Shutterstock.com. The US Food and Drug Administration (FDA) has

The Eu­ro­pean Par­lia­ment’s pub­lic health com­mit­tee will meet next Tues­day to dis­cuss and vote on long-await­ed leg­isla­tive fix­es meant to en­cour­age more bio­phar­ma in­vest­ment across